Inflammation as a tumor promoter in cancer induction.

By M. Philip, D. Rowley, H. Schreiber. Seminars in Cancer Biology, 2004

643 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics (2007, background): “On the other hand, acute inflammation may contribute to the regression of cancer [181].”
Inflammation: gearing the journey to cancer. (2008, background): “Inflammation acts as a key regulator of tumor promotion and progression by several mechanisms including acceleration of cell cycle progression and cell proliferation, evasion from apoptotic cell death, and stimulation of tumor neovascularization [63,64].”
Inflammation and Cancer (2019, background): “In later discussion, we will find that inflammation may contribute to the formation of these cancer phenotypes.[10]”
Inflammation, a Key Event in Cancer Development (2006, background): “Inflammation: From Acute to Chronic Inflammation is a physiologic process in response to tissue damage resulting from microbial pathogen infection, chemical irritation, and/or wounding (2).”
NF-κB: linking inflammation and immunity to cancer development and progression (2005, background): “Although the immunosurveillance hypothesis has received some experimental suppor”